The U.S. FDA approved InvaGen Pharmaceuticals’ generic version of Pfizer’s Lyrica (pregabalin) for eight different dosages.

(Reuters Health) – The shingles vaccine might not be cost-effective for people in their fifties, a new analysis suggests. The Centers for Disease Control and Prevention (CDC) does not recommend the shingles vaccine for that age group, and the authors of the new analysis say their findings support that policy. “Even though the vaccine is […]